⌘K

Login Start Free

Home/Filings/4/0000950170-24-024922

4//SEC Filing

Gergen Mark J 4

Accession 0000950170-24-024922

CIK 0001661460other

View on SEC.gov Company Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 5:18 PM ET

Size

4.8 KB

Accession

0000950170-24-024922

Insider Transaction Report

Form 4

Period: 2024-03-01

Poseida Therapeutics, Inc.PSTX

DirectorExecutive Chairman

Transactions

Tax Payment
Common Stock
2024-03-01$4.13/sh−34,157$141,068→ 651,291 total

Footnotes (1)

[F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on March 1, 2023.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Poseida Therapeutics, Inc.

CIK 0001661460

Entity typeother

Related Parties

1

filerCIK 0001373110

Filing Metadata

Form type: 4
Filed: Mar 3, 7:00 PM ET
Accepted: Mar 4, 5:18 PM ET
Size: 4.8 KB

View on SEC.gov